NTN BUZZTIME INC License Agreements
5 Contracts & Agreements
- First Amendment to Exclusive License Agreement, dated as of July 12, 2023, by and between Eterna Therapeutics Inc. and Factor Bioscience Limited (Filed With SEC on July 13, 2023)
- Exclusive License Agreement, dated February 20, 2023, by and between Factor Bioscience Limited and Eterna Therapeutics Inc (Filed With SEC on February 22, 2023)
- First Amendment to Exclusive License Agreement, dated November 22, 2022, by and among Eterna Therapeutics Inc., Brooklyn Immunotherapeutics LLC, Novellus Therapeutics Limited and... (Filed With SEC on November 22, 2022)
- Third Amended and Restated Exclusive License Agreement, dated November 1, 2020, by and between Factor Bioscience Limited and Novellus Therapeutics Limited (Filed With SEC on November 14, 2022)
- Exclusive License Agreement, dated as of April 26, 2021, between Factor Bioscience Limited, Novellus Therapeutics Limited and Brooklyn ImmunoTherapeutics LLC (Filed With SEC on April 30, 2021)
